Ted A.

Ted A. is an Associate Director in Software Engineering at Seres Therapeutics since September 2018. Prior to that, Ted held roles in bioinformatics engineering, software development, and leadership positions at various companies such as Blueprint Medicines, Merck, Knome, and Black Duck Software. Ted also has a background in research assistance focusing on natural language processing. Ted holds a Master's degree in Bioinformatics from Northeastern University and a Bachelor's degree in Computer Science from the University of Massachusetts Amherst.